Roivant Sciences (ROIV) Divestments (2023 - 2024)
Roivant Sciences (ROIV) posted Divestments of $185.6 million for Q4 2024, up 290.71% on a QoQ basis from $47.5 million in Q4 2023, and up 290.71% year-over-year from $47.5 million in Q1 2024.
Roivant Sciences (ROIV) Divestments (2023 - 2024) Analysis & Trends
Roivant Sciences' Divestments history runs 2 years deep, the most recent figure standing at $185.6 million for Q4 2024.
- Quarterly Divestments rose 290.71% year-over-year to $185.6 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $233.1 million (changed N/A YoY) and the FY2025 annual result came in at $260.6 million, up 448.6% from the prior year.
- Divestments was $185.6 million for Q4 2024 at Roivant Sciences, up from $47.5 million in the prior quarter.
- Across five years, Divestments topped out at $185.6 million in Q4 2024 and bottomed at $47.5 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -32.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 185.59 Mn |
| Dec 31, 2023 | 47.50 Mn |